Shuji Ohta

980 total citations
24 papers, 586 citations indexed

About

Shuji Ohta is a scholar working on Rheumatology, Physiology and Organic Chemistry. According to data from OpenAlex, Shuji Ohta has authored 24 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 5 papers in Physiology and 4 papers in Organic Chemistry. Recurrent topics in Shuji Ohta's work include Salivary Gland Disorders and Functions (4 papers), Melanoma and MAPK Pathways (3 papers) and Systemic Lupus Erythematosus Research (3 papers). Shuji Ohta is often cited by papers focused on Salivary Gland Disorders and Functions (4 papers), Melanoma and MAPK Pathways (3 papers) and Systemic Lupus Erythematosus Research (3 papers). Shuji Ohta collaborates with scholars based in Japan, Czechia and United States. Shuji Ohta's co-authors include Naoyuki Kamatani, Masako Hara, Chikako Fukasawa, Tomoko Sugiura, Masayoshi Harigai, Noriko Iikuni, Kae Takagi, Yasushi Kawaguchi, Hiroshi Okamoto and Michi Tanaka and has published in prestigious journals such as The Journal of Immunology, Emerging infectious diseases and Bioorganic & Medicinal Chemistry.

In The Last Decade

Shuji Ohta

24 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuji Ohta Japan 12 221 160 147 115 92 24 586
B. Heilig Germany 10 126 0.6× 71 0.4× 197 1.3× 144 1.3× 110 1.2× 24 488
Manuel Almagro Spain 13 73 0.3× 119 0.7× 73 0.5× 61 0.5× 92 1.0× 49 473
Peter J. Norsworthy United Kingdom 12 264 1.2× 110 0.7× 510 3.5× 123 1.1× 108 1.2× 21 794
Schwartz Rs United States 12 213 1.0× 102 0.6× 321 2.2× 123 1.1× 108 1.2× 27 835
Nozomi Iwanaga Japan 12 238 1.1× 58 0.4× 181 1.2× 158 1.4× 67 0.7× 47 611
M.C. Honorati Italy 11 226 1.0× 86 0.5× 253 1.7× 132 1.1× 56 0.6× 18 587
María Jesús Citores Spain 15 135 0.6× 83 0.5× 292 2.0× 124 1.1× 27 0.3× 37 595
Tamsanqa Hove Netherlands 5 101 0.5× 181 1.1× 258 1.8× 86 0.7× 68 0.7× 5 576
Eleonora Ballanti Italy 12 266 1.2× 77 0.5× 357 2.4× 90 0.8× 121 1.3× 18 649
Natalie Frede Germany 11 103 0.5× 117 0.7× 567 3.9× 93 0.8× 92 1.0× 18 800

Countries citing papers authored by Shuji Ohta

Since Specialization
Citations

This map shows the geographic impact of Shuji Ohta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuji Ohta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuji Ohta more than expected).

Fields of papers citing papers by Shuji Ohta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuji Ohta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuji Ohta. The network helps show where Shuji Ohta may publish in the future.

Co-authorship network of co-authors of Shuji Ohta

This figure shows the co-authorship network connecting the top 25 collaborators of Shuji Ohta. A scholar is included among the top collaborators of Shuji Ohta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuji Ohta. Shuji Ohta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Kaneko, Makoto, et al.. (2014). Analysis of the Disposition of a Novel p38 MAPK Inhibitor, AKP-001, and Its Metabolites in Rats with a Simple Physiologically Based Pharmacokinetic Model. Drug Metabolism and Disposition. 43(2). 217–226. 5 indexed citations
5.
6.
Ogata, Atsushi, Kazuhide Tanimura, Hiroshi Inoue, et al.. (2013). Phase III Study of the Efficacy and Safety of Subcutaneous Versus Intravenous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis. Arthritis Care & Research. 66(3). 344–354. 109 indexed citations
7.
Sugai, Susumu, Hiroki Takahashi, Shuji Ohta, et al.. (2009). Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren’s syndrome: a double-blind placebo-controlled multicenter trial. Modern Rheumatology. 19(2). 114–124. 18 indexed citations
8.
Sugai, Susumu, Hiroki Takahashi, Shuji Ohta, et al.. (2008). Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren’s syndrome: a double-blind placebo-controlled multicenter trial. Modern Rheumatology. 19(2). 114–124. 18 indexed citations
9.
Iikuni, Noriko, et al.. (2006). Evaluation of Pneumocystis pneumonia infection risk factors in patients with connective tissue disease. Modern Rheumatology. 16(5). 282–288. 47 indexed citations
10.
Masuzawa, Toshiyuki, Yoshihiro Okamoto, Yumi Une, et al.. (2006). Leptospirosis in Squirrels Imported from United States to Japan. Emerging infectious diseases. 12(7). 1153–1155. 26 indexed citations
11.
Iikuni, Noriko, et al.. (2006). Evaluation ofPneumocystispneumonia infection risk factors in patients with connective tissue disease. Modern Rheumatology. 16(5). 282–288. 30 indexed citations
12.
13.
Maruya, Shin-ichiro, et al.. (2004). Inflammatory pseudotumour (plasma cell granuloma) arising in the maxillary sinus. Acta Oto-Laryngologica. 125(3). 322–327. 19 indexed citations
14.
15.
Kobashigawa, Tsuyoshi, Hiroshi Okamoto, Junko Kato, et al.. (2004). Ulcerative Colitis Followed by the Development of Behcet's Disease. Internal Medicine. 43(3). 243–247. 7 indexed citations
16.
Sugiura, Tomoko, Yasushi Kawaguchi, Masayoshi Harigai, et al.. (2000). Increased CD40 Expression on Muscle Cells of Polymyositis and Dermatomyositis: Role of CD40-CD40 Ligand Interaction in IL-6, IL-8, IL-15, and Monocyte Chemoattractant Protein-1 Production. The Journal of Immunology. 164(12). 6593–6600. 115 indexed citations
17.
Ohta, Shuji, et al.. (1994). Concise Synthesis of 7,8-Dimethoxyisochroman-3-one: Formal Synthesis of Berberine. Heterocycles. 37(2). 897–897. 2 indexed citations
18.
Ishii, Hisashi, et al.. (1993). A Convenient Preparation of Salicylaldehydes from 2-Methylbenzofurans by Ozonolysis.. Chemical and Pharmaceutical Bulletin. 41(6). 1166–1168. 7 indexed citations
19.
Ishii, Hisashi, Tsutomu Ishikawa, Shuji Ohta, Masahiro Suzuki, & Takashi Harayama. (1992). Total Synthesis of Lemaireocereine.. Chemical and Pharmaceutical Bulletin. 40(8). 1993–1996. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Heilig Breakdown of academic impact, for papers by Manuel Almagro Breakdown of academic impact, for papers by Peter J. Norsworthy Breakdown of academic impact, for papers by Schwartz Rs Breakdown of academic impact, for papers by Nozomi Iwanaga Breakdown of academic impact, for papers by M.C. Honorati Breakdown of academic impact, for papers by María Jesús Citores Breakdown of academic impact, for papers by Tamsanqa Hove Breakdown of academic impact, for papers by Eleonora Ballanti Breakdown of academic impact, for papers by Natalie Frede
Rankless by CCL
2026